Review



murine endothelial cells 3b11  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    ATCC murine endothelial cells 3b11
    Murine Endothelial Cells 3b11, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine endothelial cells 3b11/product/ATCC
    Average 94 stars, based on 14 article reviews
    murine endothelial cells 3b11 - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    Developmental Studies Hybridoma Bank mouse ms anti neuroglian bp104
    Mouse Ms Anti Neuroglian Bp104, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse ms anti neuroglian bp104/product/Developmental Studies Hybridoma Bank
    Average 94 stars, based on 1 article reviews
    mouse ms anti neuroglian bp104 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    ATCC murine endothelial cells 3b11
    Murine Endothelial Cells 3b11, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine endothelial cells 3b11/product/ATCC
    Average 94 stars, based on 1 article reviews
    murine endothelial cells 3b11 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Developmental Studies Hybridoma Bank ms anti neuroglian bp104
    Ms Anti Neuroglian Bp104, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ms anti neuroglian bp104/product/Developmental Studies Hybridoma Bank
    Average 94 stars, based on 1 article reviews
    ms anti neuroglian bp104 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Developmental Studies Hybridoma Bank anti fasciclin 3
    Anti Fasciclin 3, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti fasciclin 3/product/Developmental Studies Hybridoma Bank
    Average 94 stars, based on 1 article reviews
    anti fasciclin 3 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Developmental Studies Hybridoma Bank mouse anti fasciclin іі
    Mouse Anti Fasciclin іі, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti fasciclin іі/product/Developmental Studies Hybridoma Bank
    Average 94 stars, based on 1 article reviews
    mouse anti fasciclin іі - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Developmental Studies Hybridoma Bank neuroglian
    Analysis of AZ, SV, endocytic and cell adhesion proteins, and mitochondria upon motoneuronal Myo15 knock-down. (A) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for liprin-α (green) and HRP (magenta). (B) Quantifications of A. Liprin-α mean pixel intensity of NMJ (control 100.0 ± 8.04% n = 11; Myo15-RNAi 89.1 ± 8.38%, n = 12). (C) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Rab3 (green) and HRP (magenta). (D) Quantifications of C. Rab3 mean pixel intensity of NMJ (control 100.0 ± 2.83% n = 12; Myo15-RNAi 82.0 ± 2.36%, n = 12). (E) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for DAP160 (green) and HRP (magenta). (F) Quantifications of E. DAP160 mean pixel intensity of NMJ (control 100.0 ± 11.0% n = 9; Myo15-RNAi 89.95 ± 6.04%, n = 10). (G) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Nrg (green) and HRP (magenta). (H) Quantifications of G. Nrg mean pixel intensity of NMJ (control 100.0 ± 5.51% n = 11; Myo15-RNAi 105.0 ± 9.85%, n = 10). (I and J) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for ATP5 (mitochondria) (green) and HRP (magenta) with NMJ and muscle contribution, and (J) only NMJ ATP5 contribution. (K–N) Quantifications of J. (K) ATP5 spot (mitochondria) area (control 100.0 ± 5.13% n = 12; Myo15-RNAi 103.2 ± 5.22%, n = 12). (L) Density of ATP5 spots (mitochondria) as number of spots per NMJ area (control 100.0 ± 5.92% n = 12; Myo15-RNAi 97.35 ± 5.02%, n = 12). (M) ATP5 (mitochondria) mean pixel intensity of single spots (control 100.0 ± 11.67% n = 12; Myo15-RNAi 91.4 ± 10.06%, n = 12). (N) Total ATP5 (mitochondria) intensity as integral of the ATP5 mean pixel intensity over the entire NMJ (control 100.0 ± 11.04% n = 12; Myo15-RNAi 101.4 ± 11.71%, n = 10). (O) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Rbsn-5 (EE) (green) and HRP (magenta) with NMJ and muscle contribution. For all images, scale bar overview 5 µm, zoom 2 µm. All data are provided as mean ± SEM. N represents NMJs with 1–2 NMJs/animal from five to six animals, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Nrg, <t>neuroglian.</t>
    Neuroglian, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/neuroglian/product/Developmental Studies Hybridoma Bank
    Average 94 stars, based on 1 article reviews
    neuroglian - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Developmental Studies Hybridoma Bank mouse anti neuroglian
    Analysis of AZ, SV, endocytic and cell adhesion proteins, and mitochondria upon motoneuronal Myo15 knock-down. (A) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for liprin-α (green) and HRP (magenta). (B) Quantifications of A. Liprin-α mean pixel intensity of NMJ (control 100.0 ± 8.04% n = 11; Myo15-RNAi 89.1 ± 8.38%, n = 12). (C) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Rab3 (green) and HRP (magenta). (D) Quantifications of C. Rab3 mean pixel intensity of NMJ (control 100.0 ± 2.83% n = 12; Myo15-RNAi 82.0 ± 2.36%, n = 12). (E) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for DAP160 (green) and HRP (magenta). (F) Quantifications of E. DAP160 mean pixel intensity of NMJ (control 100.0 ± 11.0% n = 9; Myo15-RNAi 89.95 ± 6.04%, n = 10). (G) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Nrg (green) and HRP (magenta). (H) Quantifications of G. Nrg mean pixel intensity of NMJ (control 100.0 ± 5.51% n = 11; Myo15-RNAi 105.0 ± 9.85%, n = 10). (I and J) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for ATP5 (mitochondria) (green) and HRP (magenta) with NMJ and muscle contribution, and (J) only NMJ ATP5 contribution. (K–N) Quantifications of J. (K) ATP5 spot (mitochondria) area (control 100.0 ± 5.13% n = 12; Myo15-RNAi 103.2 ± 5.22%, n = 12). (L) Density of ATP5 spots (mitochondria) as number of spots per NMJ area (control 100.0 ± 5.92% n = 12; Myo15-RNAi 97.35 ± 5.02%, n = 12). (M) ATP5 (mitochondria) mean pixel intensity of single spots (control 100.0 ± 11.67% n = 12; Myo15-RNAi 91.4 ± 10.06%, n = 12). (N) Total ATP5 (mitochondria) intensity as integral of the ATP5 mean pixel intensity over the entire NMJ (control 100.0 ± 11.04% n = 12; Myo15-RNAi 101.4 ± 11.71%, n = 10). (O) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Rbsn-5 (EE) (green) and HRP (magenta) with NMJ and muscle contribution. For all images, scale bar overview 5 µm, zoom 2 µm. All data are provided as mean ± SEM. N represents NMJs with 1–2 NMJs/animal from five to six animals, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Nrg, <t>neuroglian.</t>
    Mouse Anti Neuroglian, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti neuroglian/product/Developmental Studies Hybridoma Bank
    Average 94 stars, based on 1 article reviews
    mouse anti neuroglian - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    Analysis of AZ, SV, endocytic and cell adhesion proteins, and mitochondria upon motoneuronal Myo15 knock-down. (A) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for liprin-α (green) and HRP (magenta). (B) Quantifications of A. Liprin-α mean pixel intensity of NMJ (control 100.0 ± 8.04% n = 11; Myo15-RNAi 89.1 ± 8.38%, n = 12). (C) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Rab3 (green) and HRP (magenta). (D) Quantifications of C. Rab3 mean pixel intensity of NMJ (control 100.0 ± 2.83% n = 12; Myo15-RNAi 82.0 ± 2.36%, n = 12). (E) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for DAP160 (green) and HRP (magenta). (F) Quantifications of E. DAP160 mean pixel intensity of NMJ (control 100.0 ± 11.0% n = 9; Myo15-RNAi 89.95 ± 6.04%, n = 10). (G) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Nrg (green) and HRP (magenta). (H) Quantifications of G. Nrg mean pixel intensity of NMJ (control 100.0 ± 5.51% n = 11; Myo15-RNAi 105.0 ± 9.85%, n = 10). (I and J) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for ATP5 (mitochondria) (green) and HRP (magenta) with NMJ and muscle contribution, and (J) only NMJ ATP5 contribution. (K–N) Quantifications of J. (K) ATP5 spot (mitochondria) area (control 100.0 ± 5.13% n = 12; Myo15-RNAi 103.2 ± 5.22%, n = 12). (L) Density of ATP5 spots (mitochondria) as number of spots per NMJ area (control 100.0 ± 5.92% n = 12; Myo15-RNAi 97.35 ± 5.02%, n = 12). (M) ATP5 (mitochondria) mean pixel intensity of single spots (control 100.0 ± 11.67% n = 12; Myo15-RNAi 91.4 ± 10.06%, n = 12). (N) Total ATP5 (mitochondria) intensity as integral of the ATP5 mean pixel intensity over the entire NMJ (control 100.0 ± 11.04% n = 12; Myo15-RNAi 101.4 ± 11.71%, n = 10). (O) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Rbsn-5 (EE) (green) and HRP (magenta) with NMJ and muscle contribution. For all images, scale bar overview 5 µm, zoom 2 µm. All data are provided as mean ± SEM. N represents NMJs with 1–2 NMJs/animal from five to six animals, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Nrg, neuroglian.

    Journal: The Journal of Cell Biology

    Article Title: Myosin 15 participates in assembly and remodeling of the presynapse

    doi: 10.1083/jcb.202305059

    Figure Lengend Snippet: Analysis of AZ, SV, endocytic and cell adhesion proteins, and mitochondria upon motoneuronal Myo15 knock-down. (A) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for liprin-α (green) and HRP (magenta). (B) Quantifications of A. Liprin-α mean pixel intensity of NMJ (control 100.0 ± 8.04% n = 11; Myo15-RNAi 89.1 ± 8.38%, n = 12). (C) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Rab3 (green) and HRP (magenta). (D) Quantifications of C. Rab3 mean pixel intensity of NMJ (control 100.0 ± 2.83% n = 12; Myo15-RNAi 82.0 ± 2.36%, n = 12). (E) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for DAP160 (green) and HRP (magenta). (F) Quantifications of E. DAP160 mean pixel intensity of NMJ (control 100.0 ± 11.0% n = 9; Myo15-RNAi 89.95 ± 6.04%, n = 10). (G) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Nrg (green) and HRP (magenta). (H) Quantifications of G. Nrg mean pixel intensity of NMJ (control 100.0 ± 5.51% n = 11; Myo15-RNAi 105.0 ± 9.85%, n = 10). (I and J) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for ATP5 (mitochondria) (green) and HRP (magenta) with NMJ and muscle contribution, and (J) only NMJ ATP5 contribution. (K–N) Quantifications of J. (K) ATP5 spot (mitochondria) area (control 100.0 ± 5.13% n = 12; Myo15-RNAi 103.2 ± 5.22%, n = 12). (L) Density of ATP5 spots (mitochondria) as number of spots per NMJ area (control 100.0 ± 5.92% n = 12; Myo15-RNAi 97.35 ± 5.02%, n = 12). (M) ATP5 (mitochondria) mean pixel intensity of single spots (control 100.0 ± 11.67% n = 12; Myo15-RNAi 91.4 ± 10.06%, n = 12). (N) Total ATP5 (mitochondria) intensity as integral of the ATP5 mean pixel intensity over the entire NMJ (control 100.0 ± 11.04% n = 12; Myo15-RNAi 101.4 ± 11.71%, n = 10). (O) Confocal images of RNAi-mediated Myo15 knock-down and control NMJs stained for Rbsn-5 (EE) (green) and HRP (magenta) with NMJ and muscle contribution. For all images, scale bar overview 5 µm, zoom 2 µm. All data are provided as mean ± SEM. N represents NMJs with 1–2 NMJs/animal from five to six animals, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Nrg, neuroglian.

    Article Snippet: Neuroglian (Nrg, anti-mouse, 1:50) , Developmental Studies Hybridoma Bank , BP 104.

    Techniques: Knockdown, Control, Staining